Modified Nucleosides
9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine
Quick view. We supply 9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 16006-64-7. Catalog target purity: Specification on request.
Product profile
9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine is classified as nucleoside or protected nucleoside intermediate (Formula C11H14N4O3; molecular weight 250.25).
9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 9-(2-Deoxypentofuranosyl)-6-methyl-9H-purine
- 6-methylpurine 2'-deoxyriboside
- 6-Methylpurine-2’-deoxy-β-D-riboside
- 6-METHYLPURINE-2-DEOXY-BETA-D-RIBOSIDE
- 9-(2-Deoxy-β-D-ribofuranosyl)-6-methylpurine
- 6-Methyl purine-2’-deoxy-beta-D-riboside, MePdR
- 9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine
- 9H-Purine, 9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-methyl-
Useful catalog search terms
- CAS 16006-64-7
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C11H14N4O3/c1-6-10-11(13-4-12-6)15(5-14-10)9-2-7(17)8(3-16)18-9/h4-5,7-9,16-17H,2-3H2,1H3 |
|---|---|
| InChIKey | SJXRKKYXNZWKDB-UHFFFAOYSA-N |
| SMILES | Cc1ncnc2c1ncn2C1CC(O)C(CO)O1 |
| Boiling point | 544.7±60.0 °C(Predicted) |
| Density | 1.67±0.1 g/cm3(Predicted) |
| pKa | 13.80±0.60(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for 9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0814 and CAS 16006-64-7, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.